InSilicoTrials Technologies SpA is an SME promoting innovation in healthcare by creating a cloud platform that enables widespread commercialization of high impact in silico tools for modelling and simulations. Among its assets, IST has a partnership with ANSYS, a 5-year collaboration with FDA, and is participating in five projects under the EU program Horizon 2020.